1. Address potentially life-threatening problems:
Priorities as for any emergency patient: triage, address potentially life-threatening problems, implement stabilisation measures, provide analgesia
The most urgent problems may be extra-cranial; their treatment may have beneficial effects on the brain too (e.g. draining severe pneumothorax may systemic and cerebral oxygenation, reduce patient distress etc.).
2. Primary and Secondary TBI:
Primary injury, e.g.
- Contusion – parenchymal haemorrhage and oedema
- Extra-axial haemorrhage
Immediate result of traumatic event; will already have occurred by presentation.
Prime aim is to LIMIT SECONDARY BRAIN INJURY due to e.g.
- Ischaemia from hypoperfusion
- Raised intracranial pressure (ICP)
- Active haemorrhage
- Blood brain barrier compromise
“The priority is to ensure that the brain receives an adequate supply of well-oxygenated…arterial blood in a patient with adequate ventilation.”
Treatment for possible raised ICP is one part of this therapy.
Secondary injury also affected by hypo/hypercapnia, hyperthermia, hypo/hyperglycaemia
3. Ensuring adequate oxygenation and ventilation:
Adequate brain oxygen supply depends on:
- Adequate cerebral blood flow
- Adequately oxygenated cerebral blood supply
Adequately oxygenated cerebral blood supply:
Routine approach to monitoring and supplementing systemic arterial oxygenation
Failure to achieve adequate oxygenation non-invasively necessitates intubation and ventilation +/- anaesthesia depending on patient’s status; practical and financial implications may be preclusive.
Note that excessive oxygenation may also be harmful by promoting oxidative injury; oxidative injury is one of the main mechanisms of secondary injury in TBI. Hyperoxia only really of concern in intubated patients on high FiO2 supplementation.
“if you have any doubt about the patient’s oxygenation status, then take a liberal approach to supplementation.”
Carbon dioxide status predominantly determined by ventilation
Hyperventilation lowers arterial CO2 levels causing cerebral vasoconstriction and potentially reducing ICP; but cerebral vasoconstriction also reduces cerebral perfusion which could be more harmful than the raised ICP attempting to be addressed.
Hyperventilation may worsen morbidity and mortality and inducing hypocarbia is no longer recommended
Hyercarbia should also be avoided; recommended target PaCO2/end-tidal CO2 approximately 35-45 mmHg, i.e. within normal range.
Requires access to arterial blood gas analysis or capnograph/capnometer
Difficult to influence ventilation too much unless patient is intubated but nevertheless, e.g. drain pneumothorax, treat pain etc.
4. Ensuring adequate cerebral perfusion:
Other key component to ensuring brain receives adequate supply of well-oxygenated blood Cerebral perfusion pressure (CPP) = Mean systemic arterial blood pressure (MAP) – Intracranial pressure (ICP)
In healthy brain autoregulatory homeostatic mechanisms protect cerebral blood flow over a range of MAP values
Autoregulation may be lost in injured brain; cerebral blood flow becomes even more dependent on CPP
“So this means that one of our key goals in the management of a traumatic brain injury patient is to try and maintain adequate cerebral perfusion pressure which we do by optimising the mean systemic arterial pressure and potentially trying to manipulate the intracranial pressure.”
Optimising mean systemic arterial pressure:
Head trauma patient may present with systemic hypoperfusion/hypotension due to blood loss +/- SIRS
Suggested targets include MAP 80 mmHg or systolic BP 100 mmHg; based on what evidence?
As always, priorities physical perfusion assessment and correction over BP readings
Standard approach to intravenous fluid resuscitation; replacement crystalloid typical first choice but hypertonic saline has a definite role (see below)
Vasopressor therapy if hypotension persists despite adequate fluid resuscitation (if available)
‘Conservatively aggressive’ approach: MUST RESUSCITATE SYSTEMIC PERFUSION but try to avoid overdoing it which may exacerbate cerebral oedema/raised ICP especially with a damaged blood-brain barrier.
5. Raised intracranial pressure:
Monroe-Kellie doctrine: intracranial volume = brain parenchyma + cerebral blood volume + CSF
Skull is a rigid structure so if one compartment increases in size, one or both of the other compartments has to shrink to compensate (intracranial compliance) or you will get an increase in intracranial pressure.
Parenchymal damage and blood leakage in TBI may exceed intracranial compliance capacity; raised ICP may occur.
Raised ICP will eventually compromise cerebral perfusion causing ischaemia; eventually global brain ischaemia and subsequent brain death results.
Detecting raised ICP:
Not as simple as it sounds
ICP measurement (invasive, non-invasive) is available in some human hospitals – but not veterinary centres
Measurement of optic nerve sheath diameter using ultrasonography has also been explored in human medicine; retrobulbar optic nerve sheath is continuous with the subarachnoid space so its diameter may reflect intracranial pressure.
Also some investigations into whether there is any clinically useful correlation between intraocular pressure and intracranial pressure in people.
On-going debate in human medicine is whether managing brain injury patients using ICP measurement results in better patient-centred outcomes than using clinical judgment alone; should be seen as complementary rather than independent means of patient assessment.
Cerebral ischaemic response (Cushing reflex):
Sufficient increase in ICP triggers systemic arterial hypertension as a response to try and maintain cerebral perfusion; subsequently you get reflex bradycardia.
May be reasonable to presume Cushing reflex is present in a patient with head trauma and raised ICP despite absence of bradycardia; latter is likely to ensue shortly.
Late onset phenomenon; increase in ICP likely to be substantial and potentially life-threatening when Cushing reflex detected
Other findings potentially suggestive of raised ICP:
- Unexplained deterioration in mental status
- Dilated non-responsive pupils
- Loss of physiological nystagmus
- Decerebrate posturing
- Any animal with significant head trauma??
Medical therapy for raised ICP:
Don’t overlook measures to promote venous drainage from the brain, e.g. keeping head elevated 15-30 above horizontal, minimising jugular compression.
But…most effective intervention involves medical therapy for cerebral oedema “basically trying to shrink the brain by exposing it to the dehydrating effects of hypertonic saline or mannitol”.
Both are likely to have multiple other mechanisms of action although osmotic effects most likely predominate.
Hypertonic saline vs. mannitol?
What do you have available?!
“If you do have both then you should note that at the present time, the evidence base that exists does not support one of these fluids being more effective than the other for the reduction of intracranial hypertension. You should note that the evidence base is either experimental animal models or clinical human patients.”
Normovolaemic patient: choose either first; can try the other one after if inadequate response
Hypoperfused hypovolaemic patient:
Choose hypertonic saline: restores intravascular volume and reduces intracranial pressure concurrently (albeit transiently)
Mannitol contraindicated – osmotic diuretic, may exacerbate volume status
Mannitol may require warming to dissolve crystals; hypertonic saline more convenient to use
Loop diuretic, could be used for raised ICP and may be equipotent to mannitol for this; maybe even synergistic if used with mannitol concurrently.
Avoid if hypovolaemic
“It is my understanding that the reason furosemide is not usually used instead of or in addition to mannitol is that it is more likely to cause potentially severe electrolyte abnormalities.”
When should medical therapy be used?
Not always clear but:
- Cushing response – absolute indication
- Relative indications:
- Progressive neurological signs
- Moderate-to-severe head injury refractory to aggressive extracranial stabilisation
6. Neurological examination:
Details can be found in other resources
Be careful not to draw premature conclusions, i.e. until effects of other factors (e.g. hypoperfusion, hypoxaemia, hypothermia, hypoglycaemia) influencing neurological status excluded.
Detailed neurological exam after patient stabilised; then repeat this on a regular basis for monitoring and prognostication.
7. Diagnostic imaging:
Point-of-care ultrasound evaluations of abdomen and thorax
Possible additional indications for imaging down the line e.g. fractures
- Not routinely indicated
- May reveal skull fractures but can be really difficult to obtain radiographs of interpretable quality
- Does not provide clinically useful information with respect to brain injury
“Now when it comes to more advanced imaging then aside from the issue of availability, we get into a bit of a can of worms. Some of you will be aware of the history of head CT in human trauma patients and I am not going to elaborate on that suffice to say that there is some concern about its overuse and constant discussion about what criteria should trigger a head CT to be performed. And those points apply equally to veterinary patients, likewise when we consider the use of MRI in brain injury.”
CT and MRI have relative strengths and weaknesses
MRI may provide prognostic information by detecting subtle parenchymal damage not evident on CT (e.g. Beltran et al, 2014)
Must consider risk-benefit profile of requisite patient chemical restraint – if needed
8. Other treatment considerations:
Minimise increases in cerebral metabolic rate:
Increase may worsen secondary injury
Treat seizures immediately – no evidence supporting prophylactic anticonvulsant use
Judicious sedation if distressed (flailing, constant vocalisation): opioids; anticonvulsants; conservative acepromazine or (dex)medetomidine use?
- May occur due to e.g. direct trauma to hypothalamic thermoregulatory centre; seizure activity
- Increases cellular metabolism and vasodilation leading to increased ICP
- May be neuroprotective
- Has been used in people with TBI but no consensus position about risk-benefit assessment and suitability to different patient populations
- Also logistical challenges to staff: can you actually do it? Can you provide the patient with the relevant monitoring and care they need?
(At least) One published veterinary case report (Hayes, 2009)
“I guess my take on what we should do at the moment is if the head trauma patient presents hypothermic then I would not actively warm them but take steps to prevent them getting even colder. If they are normothermic then I would maintain this. If they are hyperthermic then I would cool them to normothermia but I would not be inducing hypothermia. Having said that if I had a patient with severe brain injury where the prognosis was considered very poor-to-grave and I was working in an advanced referral setting and the pet’s carers understood the implications and lack of evidence, I would be willing to give induced hypothermia a go on the basis that in this individual patient in these clinical circumstances, the potential benefit could be justified. But I stress that is a very unfounded personal position.”
**Should be one of the first considerations after rapid baseline neurological exam!**
Alleviating pain is a key aim in all clinical patients from a welfare point of view; may have to assume its presence and treat empirically with TBI patients.
May allow more reliable rather than less reliable neurological exam to be performed (e.g. by relieving pain-induced distress)
Use pure (mu-agonist) opioid
NSAIDs contraindicated in hypovolaemic patients
Possible role for ketamine as analgesic +/- sedative. More in this podcast episode.
“The use of methylprednisolone succinate for central nervous system injury was a longstanding practice in both human and veterinary medicine. However it was not one based on sound clinical evidence. More recent clinical trials in humans have not shown positive effects on outcome and some have suggested possible increases in morbidity and/or mortality. Considering the potential adverse effects (e.g. gastrointestinal ulceration, increased risk of infection/immunosuppression, hyperglycaemia, increased catabolism) of these agents, current recommendations are that methylprednisolone or indeed any other steroid should not be used for traumatic brain injury.”
Recommendation extrapolated from human medicine…
“But it seems to me that if there is no good evidence showing that steroids are beneficial for CNS injury in dogs and cats and if the current consensus is not to use them in people, who after all are another mammalian species, then we should not be using them in dogs and cats either at the moment.”
Potential role of steroids in patients with other types of brain problems is a separate discussion
Anti-inflammatory dose corticosteroids (e.g. dexamethasone 0.1 mg/kg) occasionally indicated for significant soft tissue swelling due to head trauma
Hyperglycaemia following traumatic brain injury:
Likely due to (at least in part) to sympathetic catecholamine response
Generally said to be associated with increased mortality or at least worsened neurological outcomes in humans and experimental animals; some more recent potentially discordant evidence.
Does hyperglycaemia actually worsen the brain injury, is it just a marker of injury severity, or both?
“Even if the hyperglycaemia is detrimental, maintaining normal blood glucose levels within tight limits is controversial in human patients with severe TBI, because hypoglycaemia, a common complication of tight glucose control, can induce and aggravate underlying brain injury. As far as I am aware the majority of currently available clinical evidence in people does not support tight glucose control during the acute care of patients with severe TBI.”
Veterinary clinical evidence very poor
Hyperglycaemia likely to be marker of severity of TBI at least
No current evidence showing detrimental effect on outcome; same risks associated with tight glucose control apply as for people
“Therefore specific therapy to try and lower blood glucose is not indicated but it is important to try and avoid iatrogenic hyperglycaemia if possible – e.g. don’t use corticosteroids!”
“….even if there is a correlation between the severity of traumatic brain injury and the level of hyperglycaemia that does not mean that we can use the blood glucose prognostically. It may be that there is some prognostic value in watching how the glucose trends but this has not been shown as yet and we certainly should not use a single blood glucose measurement prognostically.” (See BestBET)
“Bearing in mind what I have just said, someone had in fact asked me about the potential administration of glucose to traumatic brain injury patients. I am not sure but I think this may have been on the back of some experimental work suggesting that there may be a benefit of providing exogenous energy substrates for the brain during periods of increased cerebral metabolic demand. But it is my understanding that the current consensus is that in clinical patients we would only administer glucose if they were hypoglycaemic which can worsen the secondary injury and we would aim to maintain normal blood glucose concentration not to induce hyperglycaemia.”
Challenging in both human and veterinary patients
Desired end-point is for a live patient with a good quality of life
Avoid making too hasty judgments; avoid dragging things out when there is no point
Clinically-derived prognostic calculators (e.g. IMPACT Prognostic calculator (International Mission for Prognosis and Analysis of Clinical Trials in TBI; www.tbi-impact.org); CRASH Prognosis model (www.crash.lshtm.ac.uk)) can help to at least guide prognostication in people.
“Level of consciousness is the most reliable empirical measure of impaired cerebral function and it provides information about the functional capabilities of the cerebral cortex and the ascending reticular activating system (RAS) in the brainstem. In human and veterinary patients signs of slow but steady improvement are likely to be the most practical guide.”
Modified Glasgow Coma Scale (The Small Animal Coma Scale):
Quantitative way of grading and monitoring brain injury by scoring three categories from 1-6; the categories are motor activity; brainstem reflexes; and, level of consciousness.
In Platt et al, 2001 it suggested that:
- MGCS 3-8 implies grave prognosis
- MGCS 9-14 implies guarded prognosis
- MGCS 15-18 implies good prognosis
- Only included dogs
- Dogs with polysystemic trauma excluded – common in head trauma patients and may affect prognosis
“As far as prognosticating on the basis of a specific MGCS score I don’t think it can be argued that this study is adequate for that purpose when critiqued from an evidence-based point of view. But as long as we keep that in mind we definitely can use the MGCS as a tool to monitor our patients and objectively assess progression rather than as a prognostic indicator. So perform an assessment early on and then repeat it at regular intervals to monitor progress. Undoubtedly the lower the score the poorer the prognosis but be careful about over-committing on the basis of this single study.”
“And in fact very recently in 2014 the MGCS has been modified further and made available for free as an app for iOS and Android. The app allows users to use the MGCS to assess their patient’s neurological status and prognosticate – bearing in mind the caveats – but it also allows this data to be submitted to a server database. Furthermore two weeks later the user is asked to submit further information for the same patient in terms of progression and outcome. In this way it is hoped that real clinical data can be collected, contribute to an evidence base and allow refinement of the MGCS especially with regard to prognostication.”
See here for more about the MGCS app.
Beltran et al, 2014 suggested that MRI could be helpful in predicting the prognosis in dogs with TBI.
Other topics not covered include nutritional support, nursing care, decompressive surgical therapy, monitoring and so on.